LONDON (dpa-AFX) - GSK plc (GSK, GSK.L) said that it has initiated the process for withdrawal of the US marketing authorization for blood cancer drug Blenrep following the request of the US Food
LONDON, Nov 22 GSK will stop selling its blood cancer drug Blenrep in the United States, it said today, representing the latest in a series of setbacks for the British.
GSK's blood cancer drug Blenrep failed the main goal of a late-stage study designed to show it was better than an existing treatment on the market, the company said on Monday.
pelosi called fir his resignation. he spoke about it this morning. i made a mistake. there is no other way to say it. i got into a topic that i shouldn t have, and i screwed up. to make a gaffe and a mistake like this is inexcuse able enrep reprehensible. i feel i let the president down. joining me now is elise jordan. it seems like what happened yesterday may be part of a broader problem for the white house. they are struggling with how it relates to syria because they have not enumerated their policy. what do you make of it. i it is a more of a problem.